The market for Lateral Flow Assay (LFA) components was valued at USD 490.8 Million in 2021 and is anticipated to grow at a 4.1% revenue CAGR over the next five years. Major factors influencing market revenue growth include the rising adoption of lateral flow assay devices in domestic settings for the early detection and diagnosis of infectious diseases, expanding technological advancements in...